{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:11:20Z","timestamp":1790907080482,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ygyno.2011.05.021","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T20:26:31Z","timestamp":1308947191000},"page":"5-12","source":"Crossref","is-referenced-by-count":82,"title":["Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas"],"prefix":"10.1016","volume":"123","author":[{"given":"Alison M.","family":"Karst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Levanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekhar","family":"Duraisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ygyno.2011.05.021_bb0005","first-page":"766","article-title":"Ovarian cancer. Clinical practice guidelines in oncology","volume":"6","author":"Morgan","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"issue":"2 Suppl 2","key":"10.1016\/j.ygyno.2011.05.021_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2007.03.012","article-title":"The management of recurrent ovarian cancer","volume":"34","author":"Bukowski","year":"2007","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ygyno.2011.05.021_bb0020","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: a model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J Oncol"},{"issue":"32","key":"10.1016\/j.ygyno.2011.05.021_bb0025","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ygyno.2011.05.021_bb0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"7216","key":"10.1016\/j.ygyno.2011.05.021_bb0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"22","key":"10.1016\/j.ygyno.2011.05.021_bb0050","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2011.05.021_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0962-8924(00)01786-4","article-title":"Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin\/Op18","volume":"10","author":"Andersen","year":"2000","journal-title":"Trends Cell Biol"},{"issue":"19","key":"10.1016\/j.ygyno.2011.05.021_bb0060","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/j.1460-2075.1996.tb00914.x","article-title":"Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics","volume":"15","author":"Marklund","year":"1996","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.ygyno.2011.05.021_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tcb.2005.05.008","article-title":"p27(Kip1) and stathmin share the stage for the first time","volume":"15","author":"Iancu-Rubin","year":"2005","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","article-title":"p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion","volume":"7","author":"Baldassarre","year":"2005","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ygyno.2011.05.021_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0b013e3181ecdee1","article-title":"A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube","volume":"17","author":"Mehrad","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.021_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1593\/neo.91542","article-title":"Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival","volume":"12","author":"Clauss","year":"2010","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.ygyno.2011.05.021_bb0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2009.08.023","article-title":"Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma","volume":"115","author":"Liu","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"18","key":"10.1016\/j.ygyno.2011.05.021_bb0090","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ygyno.2011.05.021_bb0095","article-title":"Ex vivo culture of primary human fallopian tube epithelial cells","volume":"51","author":"Fotheringham","year":"2011","journal-title":"JoVE"},{"issue":"25","key":"10.1016\/j.ygyno.2011.05.021_bb0100","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.95.25.14723","article-title":"Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization","volume":"95","author":"Counter","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.ygyno.2011.05.021_bb0105","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/MCB.22.7.2111-2123.2002","article-title":"Enumeration of the simian virus 40 early region elements necessary for human cell transformation","volume":"22","author":"Hahn","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.021_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(03)00550-6","article-title":"Telomerase maintains telomere structure in normal human cells","volume":"114","author":"Masutomi","year":"2003","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ygyno.2011.05.021_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.2624","article-title":"The Li\u2013Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal fallopian tube","volume":"220","author":"Xian","year":"2010","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.ygyno.2011.05.021_bb0125","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.021_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcb.20187","article-title":"The role of stathmin in the regulation of the cell cycle","volume":"93","author":"Rubin","year":"2004","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.ygyno.2011.05.021_bb0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.021_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2011.05.021_bb0145","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"issue":"19","key":"10.1016\/j.ygyno.2011.05.021_bb0155","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1101\/gad.13.19.2490","article-title":"Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a","volume":"13","author":"Murphy","year":"1999","journal-title":"Genes Dev"},{"issue":"43","key":"10.1016\/j.ygyno.2011.05.021_bb0160","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1038\/sj.onc.1202986","article-title":"Down-regulation of the stathmin\/Op18 and FKBP25 genes following p53 induction","volume":"18","author":"Ahn","year":"1999","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ygyno.2011.05.021_bb0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z","article-title":"p53-mediated negative regulation of stathmin\/Op18 expression is associated with G(2)\/M cell-cycle arrest","volume":"88","author":"Johnsen","year":"2000","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2011.05.021_bb0170","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.onc.1209864","article-title":"Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53","volume":"26","author":"Alli","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ygyno.2011.05.021_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"10.1016\/j.ygyno.2011.05.021_bb0180","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"Saal","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"43","key":"10.1016\/j.ygyno.2011.05.021_bb0185","doi-asserted-by":"crossref","first-page":"43ra55","DOI":"10.1126\/scitranslmed.3001065","article-title":"Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors","volume":"2","author":"Andersen","year":"2010","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.ygyno.2011.05.021_bb0190","first-page":"585","article-title":"Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity","volume":"152","author":"Jordan","year":"1998","journal-title":"Am J Pathol"},{"issue":"17","key":"10.1016\/j.ygyno.2011.05.021_bb0195","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/jnci\/90.17.1284","article-title":"Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma","volume":"90","author":"Cordon-Cardo","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ygyno.2011.05.021_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.1011","article-title":"p27\/kip1 expression in normal epithelium, benign and neoplastic breast lesions","volume":"196","author":"De Paola","year":"2002","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.ygyno.2011.05.021_bb0205","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"issue":"5","key":"10.1016\/j.ygyno.2011.05.021_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat Rev Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811004185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T17:04:14Z","timestamp":1592672654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811004185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0090825811004185"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.05.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}